In acute myeloid leukemia (AML), mutations in DNA methylation regulators such as DNMT3A, TET2, IDH1 and IDH2 are frequent, and loss of function of TET2 and DNMT3A are early events in leukemogenesis [9]. Here, IDH2 is linked to acute myeloid leukemia.